Targeting mesothelin-CD24 axis repolarizes tumor-associated macrophages to potentiate PD-1 blockade therapy in high-grade serous ovarian cancer
2025 · Journal for ImmunoTherapy of Cancer · 15 citations
https://doi.org/10.1136/jitc-2024-011230
Y
Yiying Wang
Claim or correct this author profile
Claim this profile or suggest corrections to the name, affiliation, bio, photo, or paper titles. Approved changes appear as verified CitedEvidence overlays.
42
Papers
125
Citations
6
h-index
5
i10-index
Yiying Wang is an academic researcher from Shanghai University of Traditional Chinese Medicine. The author has contributed to research in topics: Immunotherapy and Immune Responses & Glycosylation and Glycoproteins Research & Gut microbiota and health. The author has an h-index of 6, co-authored 36 publications.
ORCID: 0000-0002-9661-6111Papers by this author
worksSupplementary Data from Attenuation of sialylation augments antitumor immunity and improves response to immunotherapy in ovarian cancer
2024 · 0 citations
https://doi.org/10.1158/0008-5472.27027782
Data from Attenuation of sialylation augments antitumor immunity and improves response to immunotherapy in ovarian cancer
2024 · 0 citations
https://doi.org/10.1158/0008-5472.c.6711188.v3
Supplementary Data from Attenuation of sialylation augments antitumor immunity and improves response to immunotherapy in ovarian cancer
2024 · 0 citations
https://doi.org/10.1158/0008-5472.27027779.v1
S1P2 Reduces Mast Cell Activation and Colonic Inflammation of L-Arginine-Induced Acute Pancreatitis
2026 · Digestive Diseases and Sciences · 0 citations
https://doi.org/10.1007/s10620-026-09769-x
Research topics
topicsChat about Author
Papers
Chat
Click to start Chat